INTRODUCTION
JNK (c-Jun N-terminal kinase) is a member of the family of MAPKs (mitogen-activated protein kinases), which are ubiquitously expressed and evolutionarily conserved. JNK is activated not only by many types of external stress, including changes in osmolarity, heat shock and UV-irradiation, but also by LPA (lysophosphatidic acid) and inflammatory cytokines. Activated JNK phosphorylates the transcription factors c-Jun, Jun D and ATF-2 (activating transcription factor 2) to regulate gene expression governing stress responses. JNK signalling is also involved in the normal physiological processes of cell proliferation, apoptosis, differentiation and cell migration [1, 2] .
Activation of JNK requires the phosphorylation of the tyrosine and threonine residues located in a threonine-proline-tyrosine motif in the activation loop between regions VII and VIII of the kinase domain. This phosphorylation is catalysed by two dual-specificity kinases, MKK4 (SEK1) and MKK7. MKK4 and MKK7 are MAPKKs (MAPK kinases) that are activated by various MAPKKKs (MAPKK kinases), including MLKs (mixed lineage protein kinases), MEKK1 {MEK [MAPK/ERK (extracellular-signal-regulated kinase) kinase] kinase}, TAK1 [TGF (transforming growth factor)-β-activated kinase 1] and ASK1 (apoptosis signal-regulating kinase) [1, 2] . In-depth studies of JNK activation have shown that MKK4 preferentially phosphorylates the tyrosine residue of the threonine-prolinetyrosine motif, whereas MKK7 preferentially phosphorylates the threonine residue. Phosphorylation of both residues in vitro results in synergistic activation of JNK [3] [4] [5] . We obtained strong in vivo support for this latter activation mechanism from our studies of murine ES (embryonic stem) cells bearing disruptions of the mkk4 and/or mkk7 genes [6] [7] [8] . No JNK activation was observed in mkk4 −/− mkk7 −/− ES cells [9] . In mkk7 −/− ES cells, a severe impairment of JNK activation was observed that was accompanied by loss of phosphorylation of the threonine residue of JNK; however, there was no significant reduction in the phosphorylation of the tyrosine residue of JNK. In mkk4 −/− ES cells, reductions in the phosphorylation of both the tyrosine and threonine residues of JNK were noted. These results indicated
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that tyrosine phosphorylation by MKK4, followed by threonine phosphorylation by MKK7, leads to synergistic JNK activation in stress-stimulated ES cells. However, the molecular mechanism underlying the sequential phosphorylation of JNK by MKK4 and MKK7 remains to be elucidated. Recent studies have shown that scaffold proteins mediate the structural and functional organization of a three-tier MAPK activation module which involves a MAPKKK, a MAPKK and a MAPK [10] . These MAPK-specific scaffold proteins link these kinases into a multienzyme complex and provide an insulated physical conduit through which signals from a MAPK can be transmitted to the appropriate spatiotemporal cellular loci. [11] . We therefore speculated that additional scaffold molecules must exist that can bind to and connect two sets of complexes, one containing MKK4 and the other containing MKK7. To identify these presumed 'binder' molecules, we used MKK7 and the yeast two-hybrid method to screen a human leucocyte cDNA library. We isolated Filamin A, which has been previously reported to interact with MKK4 [12] , as a predicted 'binder' protein that can also interact with MKK7. Our results show that different MKK7 splice isoforms [13] have different scaffold-binding properties, and that Filamin A plays an important role in synergistic JNK activation.
EXPERIMENTAL

Cell culture
HEK (human embryonic kidney)-293T cells, HeLa cells and nontransfected (M2) or stably transfected (A7) human melanoma cell lines were maintained in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % FCS (fetal calf serum), 0.16 % NaHCO 3 and 0.6 mg · ml −1 L-glutamine. To maintain Filamin A expression, A7 cells were cultured in the presence of 0.5 mg/ml G418 (Sigma).
Antibodies and GFP (green fluorescent protein) vector
Abs (antibodies) against human Filamin A (MAB1680) were from Chemicon. Abs against SAPK/JNK1 (C-17 and FL) or phospho-SAPK/JNK (#9251) were from Santa Cruz Biotechnology and Cell Signaling Technology respectively. Anti-FLAG (M2) and anti-c-Myc (9E10) Abs were from Sigma-Aldrich. Anti-HA (haemagglutinin) high-affinity (3F10) Ab was from Roche Diagnostics. The rat anti-MKK7 (KN-004) mAb (monoclonal Ab) used for immunoprecipitation and immunoblotting was prepared in our laboratory as previously described [7] . Abs against MKK4 (sc-837) or phospho-MKK4 (#9151) were from Santa Cruz Biotechnology and Cell Signaling Technology respectively. The pEGFP-C1 vector was from BD Biosciences.
Construction of plasmids
cDNAs encoding FLAG-tagged versions of MKK4, MKK7α1, MKK7β1, MKK7γ 1, MKK7γ 2, JNK1 and full-length Filamin A were cloned into the mammalian expression vector pCMV5. Plasmids expressing Myc-tagged full-length Filamin A, the Myctagged CT (C-terminus) of Filamin A (residues 2282-2647), or Myc-Filamin B, Myc-Filamin C or HA-tagged MKK4 were also cloned into pCMV5. Myc-tagged Filamin A deletion mutants A, B and C were generated using PCR and subcloned into pCMV5. FLAG-tagged MKK7 deletion mutants A, B and C were constructed using a One Day Mutagenesis kit (QuikChange ® kit from Stratagene) and cloned into pCMV5.
Transfection
For gene expression analysis, HEK-293T cells were plated at 6 × 10 6 cells in a 100-mm dish, or at 2 × 10 6 cells in a 60-mm dish. Cells were transfected 1 day later with 5 μg (100-mm dish) or 1.8 μg (60-mm dish) of plasmid DNA using 5 μl of Lipofectamine TM 2000 (Invitrogen). M2 cells were plated at 1.25×10
6 cells in a 60-mm dish and transfected 1 day later with 2.5 μg of plasmid DNA as above. After 48 h in culture, cell extracts were prepared and subjected to immunoprecipitation as described below.
Immunoprecipitation and immunoblotting
Transfected HEK-293T cells were resuspended in lysis buffer A [20 mM Hepes/KOH (pH 7.4), 40 mM NaCl, 1 % Triton X-100, 1 mM dithiothreitol, 1 mM EDTA, 2 mM EGTA and 0.1 mM PMSF] at 4
• C. Cell lysates were incubated with anti-FLAG M2 agarose (Sigma) at 4
• C for 2 h. The immunocomplexes were washed several times with lysis buffer A and eluted with 200 μg/ml FLAG peptides. The eluted samples were fractionated by SDS/PAGE and proteins were electrophoretically transferred on to a PVDF membrane (Bio-Rad). Membranes were immunoblotted with anti-FLAG, anti-Myc, anti-HA or anti-(Filamin A) Abs. Bands were visualized using SuperSignal West Pico Chemiluminescent Substrate for the development of immunoblots and a HRP (horseradish peroxidase)-conjugated secondary Ab, according to the manufacturer's instructions (Pierce).
Assay of JNK and MKK7 activities
Confluent melanoma cells were treated at 37
• C for 20 min with sorbitol (50, 100, 150, 200, 300 or 500 mM). Treated cells were washed and resuspended in lysis buffer B [100 mM NaCl, 40 mM Tris/HCl (pH 8.0), 1 % Nonidet P40, 0.05 % 2-mercaptoethanol, 1 mM EDTA, 1 mM EGTA and 4 μg/ml aprotinin]. Extracts were incubated for 2 h at 4
• C with anti-JNK pAb (polyclonal antibody; C-17, Santa Cruz Biotechnology) to immunoprecipitate JNK proteins. Endogenous MKK7 proteins were immunoprecipitated in a similar manner with anti-MKK7 (KN-004) mAb. Immunocomplexes were washed three times with lysis buffer B and three times with kinase reaction buffer [10 mM MgCl 2 , 50 mM Tris/HCl (pH 7.5) and 1 mM EGTA]. JNK activity in immunoprecipitates was measured using a previously described in vitro kinase assay [6, 7] employing 60 μM [γ -32 P]ATP and GST (glutathione transferase)-c-Jun as the substrate. MKK7 activity on beads was measured using an in vitro MAPK kinase assay [6, 7] employing 100 μM unlabelled ATP with GST-JNK1 as the substrate; the product was detected using an anti-phospho-JNK Ab. For both in vitro kinase assays, the reactions were terminated after 30 min at 30
• C by the addition of 10 μl of 4×SDS gel sample buffer.
To assay JNK activity in transfected M2 cells, cells were resuspended in lysis buffer C [150 mM NaCl, 40 mM Hepes (pH 7.4), 1 % Nonidet P40, 0.05 % 2-mercaptoethanol, 1 mM EDTA, 1 mM EGTA, 10 mM MgCl 2 and 4 μg/ml aprotinin]. The resulting cell lysates were analysed by SDS/PAGE and immunoblotting in which JNK activation was detected using an anti-phospho-JNK Ab.
Yeast two-hybrid assay
A human brain cDNA library (Clontech) and the MatchMaker TM GAL4 Two-Hybrid System 3 (Clontech) were used, as described previously [14] , for a yeast two-hybrid assay in which MKK7 served as the bait.
Confocal microscopy
HeLa cells transiently expressing GFP-MKK7γ 1 were cultured on a polylysine-coated glass coverslip (15-mm diameter) and washed three times with PBS before fixation with 4 % (w/v) paraformaldehyde in PBS for 15 min at 4
• C. After treatment with 0.1 mM glycine in PBS for 15 min, the cells were permeabilized with 0.1 % Triton X-100 in blocking solution (3 % BSA in PBS) before incubation for 1 h at room temperature (25
• C) with rhodamine-conjugated phalloidin diluted in blocking solution. After three PBS washes, the coverslip was mounted on to a glass slide in Permafluor-mounting medium (Immunon) and viewed using a confocal microscope (Carl Zeiss) with LSM510 software. Excitation wavelengths of 488 nm or 546 nm were used. The images were merged using Photoshop (Adobe Systems).
For overexpression of GFP-tagged Filamin A, GFP-MKK7α1, GFP-MKK7γ 1 or GFP-MKK7 deletion B, and for co-expression of GFP-tagged MKK7γ 1 and a fusion protein composed of red fluorescent protein (DsRed) plus Filamin A, transfected HeLa cells were cultured for 48 h in a glass-based dish (35-mm diameter; Iwaki) and examined by confocal microscopy as described previously [14] .
RESULTS
Interaction of Filamin A with MKK4 and MKK7
To identify proteins that interacted with both MKK4 and MKK7, a human leucocyte cDNA library was screened with MKK7 in a yeast two-hybrid system. Among various MKK7-binding cDNAs isolated were several encoding the CT of ABP-280 (actinbinding protein-280, Filamin A), which was previously reported to bind to MKK4 [12] . To determine whether endogenous fulllength Filamin A could interact with both MKK4 and MKK7 in vivo, we transiently overexpressed FLAG-MKK4, FLAG-MKK7γ 2 and FLAG-JNK1 in HEK-293T cells and carried out co-immunoprecipitation experiments. As shown in Figure 1 (A), a protein of ∼280 kDa co-immunoprecipitated with FLAG-MKK4 and FLAG-MKK7γ 2, but not with FLAG-JNK1. We confirmed that this 280 kDa protein was indeed Filamin A using Western blotting employing anti-(Filamin A) Ab ( Figure 1B) . We next used FLAG and Myc tagging to examine whether two other members of the Filamin protein family, Filamin B and Filamin C, could bind to MKK4 and MKK7 in vivo. When overexpressed in HEK-293T cells, both Filamin B and Filamin C co-immunoprecipitated with both MKK4 and MKK7γ 2 ( Figure 1C ). These results show that Filamin family proteins can interact with at least two MAPKKs, MKK4 and MKK7γ 2, and demonstrate a novel connection between an MKK7 enzyme and a Filamin protein known to interact with MKK4.
Isoform-specific interaction of MKK7 with Filamin A
To date, six isoforms of MKK7 have been identified [12] . To test whether four of these MKK7 isoforms (Figure 2A ) interacted differentially with Filamin A, HEK-293T cells were transiently co-transfected with individual FLAG-MKK7 isoforms plus Myc-tagged Filamin A (CT). As shown in Figure 2 (B), MycFilamin A (CT) co-immunoprecipitated with FLAG-MKK7γ 2, FLAG-MKK7γ 1 and FLAG-MKK7β1, but not with FLAG-MKK7α1. We next constructed three deletion mutants of MKK7γ 1 (MKK7γ 1 deletion A, B and C; Figure 2A ) that affected the presumed Filamin-A-binding site in MKK7 and repeated the co-immunoprecipitation experiments. Myc-Filamin A (CT) co-immunoprecipitated with FLAG-MKK7γ 1 deletion A and deletion C, but not with FLAG-MKK7γ 1 deletion B or FLAG-MKK7α1 ( Figure 2C ). Thus a short N-terminal region (encompassing amino acids 31-60) that is present in MKK7γ and MKK7β, but absent in MKK7α1, is required for MKK7 binding to Filamin A.
Co-localization of MKK7 with Filamin A
To investigate whether MKK7 co-localizes with Filamin A in cells, we first examined the subcellular localization of MKK7γ 1 and found that this isoform associated with fibre-like structures. To determine whether these fibres were actin stress fibres, HeLa cells were transiently transfected with GFP-tagged MKK7γ 1, fixed, stained with phalloidin to visualize actin distribution, and examined by confocal microscopy. We observed that MKK7γ 1 did indeed co-localize with actin stress fibres ( Figure 3A ). Because Filamin A is known to cross-link actin filaments, these results suggested that MKK7γ 1 co-localized with Filamin A. We tested this possibility by transfecting HeLa cells with GFP-MKK7γ 1 and DsRed-Filamin A. As expected, MKK7γ 1 colocalized with Filamin A in selected areas ( Figure 3B ). To investigate whether the apparent association of MKK7γ 1 with actin stress fibres was due to the interaction of MKK7γ 1 with Filamin A, HeLa cells were co-transfected with GFPFilamin A and GFP-MKK7γ 1, GFP-MKK7γ 1 deletion B or GFP-phospho-MKK7α1. Confocal microscopy showed that GFP-MKK7γ 1 and GFP-Filamin A co-localized on fibre-like structures, whereas GFP-MKK7α1 and GFP-MKK7γ 1 deletion B (which do not interact with Filamin A) were diffusely distributed throughout the cytoplasm ( Figure 3C ). Thus MKK7γ 1 and Filamin A co-localize in cells, and MKK7γ 1 associates with actin stress fibres due to its interaction with Filamin A.
Filamin A mediates a connection between MKK4 and MKK7γ
The above experiments showed that Filamin A interacts not only with MKK4, but also with MKK7γ and MKKβ isoforms. To identify the regions of Filamin A that can interact with MKK4 or MKK7γ , HEK-293T cells were transiently co-transfected with either Myc-Filamin A (CT), including its MKK4-binding region (amino acids 2282-2454), or a series of Filamin A deletion mutant proteins lacking different portions of the MKK4-binding region ( Figure 4A ), together with FLAG-MKK4 or FLAG-MKK7γ 2. Co-immunoprecipitation assays showed that amino acids 2297-2311 of Filamin A were required for its interaction with MKK7γ 2 ( Figure 4B ). Thus the region of Filamin A required for binding to MKK7γ 2 is distinct from that needed for the interaction with MKK4. We then investigated whether Filamin A could interact simultaneously with MKK4 and MKK7γ 2 by transiently co-transfecting HEK-293T cells with HA-tagged MKK4 plus FLAG-MKK7γ 2 or FLAG-MKK7α1. HA-MKK4 5 and 8) or Myc-Filamin C (lanes 3, 6 and 9), together with 0.9 μg of pCMV5/FLAG (lanes 1-3) , FLAG-MKK4 (lanes 4-6) or FLAG-MKK7γ 2 (lanes 7-9). Cell lysates were prepared (panels c and d) and immunoprecipitated (IP) with anti-FLAG M2 agarose (panels a and b). Co-immunoprecipitated Myc-Filamin proteins and immunoprecipitated FLAG-MKK4 and FLAG-MKK7γ 2 were determined using anti-c-Myc (panel a) and anti-FLAG M2 (panel b) Abs respectively. Expression of Myc-Filamin proteins and FLAG-MKK4 and FLAG-MKK7γ 2 were determined using anti-c-Myc (panel c) and anti-FLAG M2 (panel d) Abs respectively. IB, immunoblot.
and endogenous Filamin A co-immunoprecipitated with FLAG-MKK7γ 2, but not with FLAG-MKK7α1 ( Figure 4C ). Because this experiment did not exclude the possibility that MKK4 might interact directly with MKK7γ 2 (rather than with Filamin A), we repeated these co-immunoprecipitation experiments using a human melanoma cell line M2 that has spontaneously lost expression of Filamin A [15] . M2 cells were transiently cotransfected with HA-MKK4 and FLAG-MKK7γ 2, together with increasing amounts of Myc-Filamin A (CT). Interaction of MKK4 with MKK7 was enhanced when higher amounts of Filamin A (CT) were present ( Figure 4D ), suggesting that Filamin A, MKK4 and MKK7γ 2 form a complex in which Filamin A connects MKK4 and MKK7γ 2.
Filamin A enhances the activation of MKK7 and JNK
The above results suggested that Filamin A might be one of the 'binder' proteins predicted to closely connect two MAPKKs within a MAPK module in living cells [11] . To examine the effect of Filamin A on JNK activation in vivo, we compared JNK activation in M2 cells (no Filamin A expression) with that in A7 cells (M2 cells stably transfected with a vector expressing full-length human Filamin A; [16] ). In response to increasing concentrations of sorbitol, JNK was activated much more strongly in A7 cells than in M2 cells ( Figure 5A ). When we analysed the activation state of MKK7 in these sorbitol-treated M2 and A7 cells, we found that 500 mM sorbitol induced a 3.3-fold activation of MKK7 in A7 cells, but only a 1.4-fold activation of MKK7 in M2 cells ( Figure 5B ). The activation of MKK4 is also higher in A7 cells than in M2 cells ( Figure 5C ). Thus, in living cells, Filamin A promotes optimal stress-induced JNK activation by enhancing MKK7 and MKK4 activation.
Finally, we analysed the effect of Filamin A on JNK activation induced by overexpression of MKK4 and/or MKK7γ 2. M2 cells were transiently transfected with FLAG-MKK4 and FLAG-MKK7γ 2, together with various amounts of FLAG-Filamin A. Overexpression of MKK7γ 2 and MKK4 induced JNK activation which was greatly enhanced when the amount of transfected Filamin A was increased ( Figure 5D, upper panel) . However, MKK4-or MKK7γ 2-induced JNK activation was not enhanced when the amount of transfected Filamin A was increased (Figure 5D, lower panel) . These results support our contention that, by physically connecting MKK4 and MKK7γ 2, Filamin A facilitates synergistic JNK activation dependent on these MAPKKs.
DISCUSSION
In vitro experiments have shown that synergistic activation of JNK requires the phosphorylation of both the threonine and tyrosine residues within the threonine-proline-tyrosine motif of JNK, and that this phosphorylation is mediated by two different enzymes, MKK4 (SEK1) and MKK7 [3] [4] [5] . Although both of these MAPKKs can catalyse the phosphorylation of both tyrosine and threonine, MKK4 preferentially phosphorylates the tyrosine residue, whereas MKK7 preferentially phosphorylates the threonine residue [3] . In a previous study of stressstimulated murine ES cells, we presented in vivo data confirming that these key tyrosine and threonine residues of JNK are sequentially phosphorylated by MKK4 and MKK7 respectively [7, 11] (Figure 6A ). The present study provides evidence that Filamin A is one of the 'binder' molecules presumed to directly and closely connect MKK4 and MKK7 so that they can mediate this tyrosine/threonine phosphorylation. We showed that Filamin A (as well as Filamin B and C) associate with MKK7 and MKK4, but not with JNK1 itself (Figure 1) . Furthermore, this association is isoform-specific, since Filamin A interacted with MKK7γ and MKK7β, but not with MKK7α ( Figure 2 ). In addition, MKK7γ (but not MKK7α) co-localized with actin filaments in a manner dependent on Filamin A binding (Figure 3) . We also showed that the MKK7-binding site of Filamin A was different from that for MKK4, and that the formation of the MKK7γ -MKK4 complex was mediated by Filamin A (Figure 4) . Lastly, we demonstrated that Filamin A was essential for strong JNK, MKK7 and MKK4 activation in response to sorbitol, as well as for induction of JNK activation by MKK4 and MKK7 ( Figure 5 ). Thus we present a novel model in which MKK4 and MKK7γ use Filamin A as a scaffold to support their sequential tyrosine/threonine phosphorylation and thus synergistic activation of JNK ( Figure 6B ).
Our work clarifies that there are at least three types of JNK activation mechanisms: (i) MKK4-mediated JNK phosphorylation, (ii) MKK7-mediated JNK phosphorylation, and (iii) JNK phosphorylation mediated by both MKK4 and MKK7. Molecular mechanisms (i) and (ii) depend on the JNK scaffold proteins JIP1, JIP2, JSAP1 and JLP, which bind to JNK and MKK4 or MKK7, but not to all three proteins [10] . In contrast, mechanism (iii) depends on a Filamin protein (A, B or C), rather than on a JIP-type protein. We speculate that, in living cells, there may be a wide variety of JNK activation and signalling modules that involve either JIP-type or Filamin-type molecules, or a combination of these scaffold proteins depending on different cell types. The ratios of the JNK signalling modules seem to vary in different cell types.
Filamin A is an actin cross-linking protein and possesses an actin-binding domain and a homodimerization domain that allow it to determine the submembranous cytoskeletal architecture of cells. Consistent with these properties, Filamin A is required for cell adhesion and migration [15] . Previous studies have shown that Filamin A interacts with MKK4 and TRAF2 [TNF (A) Synergistic activation of JNK through sequential tyrosine/threonine phosphorylation by MKK4 and MKK7 in murine cells (as reported in our previous study; [7] ). In a murine ES cell subjected to stress, activated (phosphorylated) MKK4 mediates the phosphorylation of the tyrosine residue of the threonine-proline-tyrosine motif (TPY) of JNK (step 1), followed by threonine phosphorylation of the same JNK molecule by activated (phosphorylated) MKK7 (step 2). JNK activity is synergistically enhanced. (B) MKK4 and MKK7γ are connected by their mutual interaction with Filamin A. As demonstrated in the present study, Filamin A associates with actin filaments comprising the cytoskeleton. Filamin A also contains distinct binding sites for MKK4 and MKK7, and can interact simultaneously with these MAPKKs. The interaction of all three proteins with JNK induces synergistic levels of JNK phosphorylation and thus activation.
(tumour necrosis factor)-receptor-associated factor]. TRAF2 is an intracellular adaptor protein that is involved in signal transduction from the TNF receptor and related receptors, and is required for TNF-induced JNK activation [12, 17] . Other work has indicated that Filamin A binds to small GTPases such as Rac, Rho, Cdc42 and RalA [16] . Thus many signalling molecules, including small GTPases, TRAF2 and MKK4, accumulate on Filamin A. These observations suggest that, as well as regulating cytoskeletal architecture, Filamin A may function as a signalsome that connects diverse signalling pathways, including MAPK modules. Conversely, in addition to its role in stress signalling, JNK has been implicated in cell migration and cytoskeletal reorganization. Huang et al. [18] reported that JNK1 phosphorylates paxillin, a focal adhesion adaptor, both in vitro and in intact fish and rat cells. Similarly, Otto et al. [19] identified p150-Spir, a Drosophila JNKinteracting protein, as belonging to the Wiscott-Aldrich syndrome protein homology domain-2 family of proteins involved in actin reorganization. p150-Spir is phosphorylated by JNK both in vitro and in vivo, indicating that p150-Spir is a downstream target of JNK function and providing a direct link between JNK activity and actin reorganization. Thus the downstream targets of JNK include not only transcription factors, but also cytoskeletal regulators. Another intriguing observation is that the receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating JNK via Filamin A [20] . Lastly, Filamin A is not the only Filamin family member involved in JNK signalling, as Filamin B functions as a scaffold linking activated Rac1, MEKK1 and MKK4 to JNK during type I interferon signalling [21, 22] . Taken together, these data point towards multiple connections between signalling modules and Filamin proteins.
The present study has revealed interesting differences among MKK7 isoforms. Tournier et al. [13] showed that MKK7 isoforms are present both in the cytoplasm and the nucleus, and are selectively regulated by specific extracellular stimuli. We have previously reported that treatment of ES cells with sorbitol (which affects the plasma membrane) induces stronger activation of MKK7γ 1 than MKK7α1 [6] . In the present study, we discovered that MKK7γ 1 co-localizes with actin on stress fibres and with Filamin A at the cell surface ( Figures 3A and 3B ). On the other hand, we found that MKK7α1 and MKK7γ 1 deletion B, neither of which can interact with Filamin A, were diffusely distributed throughout the cytoplasm ( Figure 3C ). These data suggest the possibility that MKK7γ 1, which co-localizes with the actin cytoskeleton right up to the plasma membrane, is involved in signal transduction from this membrane, whereas MKK7α1, which is distributed throughout the cytoplasm, is involved in a cytoplasmic signalling pathway. Thus differences in the intracellular distribution of MKK7 isoforms may correspond to different MAPK signalling modules mediating distinct cellular responses.
In conclusion, the present study has demonstrated that Filamin A interacts with specific MKK7 isoforms and is a candidate for a presumed 'binder' protein needed to form the JNK-MKK4-MKK7 MAPK module. Filamin A may support or induce the sequential phosphorylation of JNK by MKK4 and MKK7, and thus function as a signalsome involved in cytoskeletal events. Future work will establish whether Filamin A is a key factor supporting additional JNK signalling cascades.
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